394 related articles for article (PubMed ID: 20974503)
21. Synthesis and biological evaluation of novel pyrazole compounds.
Youssef AM; Neeland EG; Villanueva EB; White MS; El-Ashmawy IM; Patrick B; Klegeris A; Abd-El-Aziz AS
Bioorg Med Chem; 2010 Aug; 18(15):5685-96. PubMed ID: 20609589
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, biological evaluation, and enzyme docking simulations of 1,5-diarylpyrrole-3-alkoxyethyl ethers as selective cyclooxygenase-2 inhibitors endowed with anti-inflammatory and antinociceptive activity.
Anzini M; Rovini M; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Norcini M; Giordani A; Makovec F; Anzellotti P; Patrignani P; Biava M
J Med Chem; 2008 Aug; 51(15):4476-81. PubMed ID: 18598017
[TBL] [Abstract][Full Text] [Related]
23. Selective COX-2 inhibitors. Part 1: synthesis and biological evaluation of phenylazobenzenesulfonamides.
Tsai WJ; Shiao YJ; Lin SJ; Chiou WF; Lin LC; Yang TH; Teng CM; Wu TS; Yang LM
Bioorg Med Chem Lett; 2006 Sep; 16(17):4440-3. PubMed ID: 16814546
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of new water-soluble tetrazolide derivatives of celecoxib and rofecoxib as selective cyclooxygenase-2 (COX-2) inhibitors.
Navidpour L; Amini M; Shafaroodi H; Abdi K; Ghahremani MH; Dehpour AR; Shafiee A
Bioorg Med Chem Lett; 2006 Sep; 16(17):4483-7. PubMed ID: 16806914
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
Abdel-Aziz AA; ElTahir KE; Asiri YA
Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719
[TBL] [Abstract][Full Text] [Related]
26. Novel 5-substituted 1H-tetrazoles as cyclooxygenase-2 (COX-2) inhibitors.
Al-Hourani BJ; Sharma SK; Suresh M; Wuest F
Bioorg Med Chem Lett; 2012 Mar; 22(6):2235-8. PubMed ID: 22341941
[TBL] [Abstract][Full Text] [Related]
27. Sulfonilamidothiopyrimidone and thiopyrimidone derivatives as selective COX-2 inhibitors: synthesis, biological evaluation, and docking studies.
Basile L; Alvarez S; Blanco A; Santagati A; Granata G; Di Pietro P; Guccione S; Muñoz-Fernández MÁ
Eur J Med Chem; 2012 Nov; 57():149-61. PubMed ID: 23047231
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, biological evaluation and docking studies of novel benzopyranone congeners for their expected activity as anti-inflammatory, analgesic and antipyretic agents.
Eissa AA; Farag NA; Soliman GA
Bioorg Med Chem; 2009 Jul; 17(14):5059-70. PubMed ID: 19527932
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of 1,5-diarylpyrazol-3-propanoic acids towards inhibition of cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4 formation.
Ergün BC; Nuñez MT; Labeaga L; Ledo F; Darlington J; Bain G; Cakir B; Banoglu E
Arzneimittelforschung; 2010; 60(8):497-505. PubMed ID: 20863006
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
[TBL] [Abstract][Full Text] [Related]
31. 5-heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog.
Sakya SM; DeMello KM; Minich ML; Rast B; Shavnya A; Rafka RJ; Koss DA; Cheng H; Li J; Jaynes BH; Ziegler CB; Mann DW; Petras CF; Seibel SB; Silvia AM; George DM; Lund LA; St Denis S; Hickman A; Haven ML; Lynch MP
Bioorg Med Chem Lett; 2006 Jan; 16(2):288-92. PubMed ID: 16275075
[TBL] [Abstract][Full Text] [Related]
32. 2,3,5-Substituted tetrahydrofurans: COX-2 inhibitory activities of 5-hydroxymethyl-/carboxyl-2,3-diaryl-tetrahydro-furan-3-ols.
Singh P; Mittal A; Kaur S; Kumar S
Eur J Med Chem; 2008 Dec; 43(12):2792-9. PubMed ID: 18262309
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
Tewari AK; Singh VP; Yadav P; Gupta G; Singh A; Goel RK; Shinde P; Mohan CG
Bioorg Chem; 2014 Oct; 56():8-15. PubMed ID: 24893208
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of 3-[4-(amino/methylsulfonyl)phenyl]methylene-indolin-2-one derivatives as novel COX-1/2 and 5-LOX inhibitors.
Lai Y; Ma L; Huang W; Yu X; Zhang Y; Ji H; Tian J
Bioorg Med Chem Lett; 2010 Dec; 20(24):7349-53. PubMed ID: 21055929
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and anti-inflammatory evaluation of a series of novel amino acid-binding 1,5-diarylpyrazole derivatives.
Li MH; Yin LL; Cai MJ; Zhang WY; Huang Y; Wang X; Zhu XZ; Shen JK
Acta Pharmacol Sin; 2005 Jul; 26(7):865-72. PubMed ID: 15960895
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents.
Bandgar BP; Adsul LK; Chavan HV; Jalde SS; Shringare SN; Shaikh R; Meshram RJ; Gacche RN; Masand V
Bioorg Med Chem Lett; 2012 Sep; 22(18):5839-44. PubMed ID: 22901385
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of 4,5-diphenyloxazolone derivatives on route towards selective COX-2 inhibitors.
Dündar Y; Unlü S; Banoğlu E; Entrena A; Costantino G; Nuñez MT; Labeaga L; Sahin MF; Noyanalpan N
Eur J Med Chem; 2009 May; 44(5):1830-7. PubMed ID: 19084295
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of three 18F-labelled cyclooxygenase-2 (COX-2) inhibitors based on a pyrimidine scaffold.
Tietz O; Sharma SK; Kaur J; Way J; Marshall A; Wuest M; Wuest F
Org Biomol Chem; 2013 Dec; 11(46):8052-64. PubMed ID: 24145766
[TBL] [Abstract][Full Text] [Related]
39. New celecoxib derivatives as anti-inflammatory agents.
Szabó G; Fischer J; Kis-Varga A; Gyires K
J Med Chem; 2008 Jan; 51(1):142-7. PubMed ID: 18072726
[TBL] [Abstract][Full Text] [Related]
40. Selective COX-2 inhibitors. Part 2: synthesis and biological evaluation of 4-benzylideneamino- and 4-phenyliminomethyl-benzenesulfonamides.
Lin SJ; Tsai WJ; Chiou WF; Yang TH; Yang LM
Bioorg Med Chem; 2008 Mar; 16(5):2697-706. PubMed ID: 18063374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
